MetLife Investment Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $23M | Sell |
293,703
-5,857
| -2% | -$472K | 0.1% | 149 |
|
|
2026
Q1 | $26M | Sell |
299,560
-7,910
| -3% | -$758K | 0.13% | 116 |
|
|
2025
Q4 | $29.5M | Sell |
307,470
-10,452
| -3% | -$1.02M | 0.14% | 102 |
|
|
2025
Q3 | $30.3M | Sell |
317,922
-8,872
| -3% | -$816K | 0.15% | 96 |
|
|
2025
Q2 | $28.5M | Sell |
326,794
-6,285
| -2% | -$533K | 0.17% | 90 |
|
|
2025
Q1 | $29.9M | Sell |
333,079
-6,393
| -2% | -$572K | 0.16% | 96 |
|
|
2024
Q4 | $27.1M | Buy |
339,472
+5,939
| +2% | +$514K | 0.15% | 102 |
|
|
2024
Q3 | $30M | Sell |
333,533
-20,669
| -6% | -$1.74M | 0.17% | 93 |
|
|
2024
Q2 | $27.9M | Buy |
354,202
+42,890
| +14% | +$3.52M | 0.17% | 99 |
|
|
2024
Q1 | $27.1M | Sell |
311,312
-11,646
| -4% | -$994K | 0.18% | 91 |
|
|
2023
Q4 | $26.6M | Buy |
322,958
+319,981
| +10,748% | +$24.4M | 0.19% | 87 |
|
|
2023
Q3 | $233K | Sell |
2,977
-334,671
| -99% | -$28M | ﹤0.01% | 2115 |
|
|
2023
Q2 | $29.7M | Sell |
337,648
-5,778
| -2% | -$497K | 0.22% | 78 |
|
|
2023
Q1 | $27.7M | Sell |
343,426
-3,865
| -1% | -$315K | 0.2% | 83 |
|
|
2022
Q4 | $27M | Sell |
347,291
-5,573
| -2% | -$452K | 0.2% | 88 |
|
|
2022
Q3 | $28.5M | Sell |
352,864
-8,449
| -2% | -$759K | 0.24% | 72 |
|
|
2022
Q2 | $32.4M | Sell |
361,313
-4,508
| -1% | -$457K | 0.25% | 69 |
|
|
2022
Q1 | $40.6M | Buy |
365,821
+68,476
| +23% | +$7.23M | 0.26% | 65 |
|
|
2021
Q4 | $30.8M | Sell |
297,345
-6,190
| -2% | -$717K | 0.25% | 66 |
|
|
2021
Q3 | $38M | Sell |
303,535
-8,389
| -3% | -$1.09M | 0.34% | 52 |
|
|
2021
Q2 | $38.7M | Sell |
311,924
-9,320
| -3% | -$1.17M | 0.34% | 52 |
|
|
2021
Q1 | $37.9M | Sell |
321,244
-5,644
| -2% | -$661K | 0.35% | 48 |
|
|
2020
Q4 | $38.3M | Sell |
326,888
-13,930
| -4% | -$1.53M | 0.36% | 47 |
|
|
2020
Q3 | $35.4M | Sell |
340,818
-9,922
| -3% | -$996K | 0.39% | 45 |
|
|
2020
Q2 | $32.2M | Buy |
350,740
+5,241
| +2% | +$503K | 0.37% | 47 |
|
|
2020
Q1 | $31.2M | Sell |
345,499
-10,571
| -3% | -$1.12M | 0.42% | 41 |
|
|
2019
Q4 | $40.4M | Sell |
356,070
-9,047
| -2% | -$993K | 0.42% | 37 |
|
|
2019
Q3 | $39.7M | Sell |
365,117
-4,432
| -1% | -$462K | 0.44% | 37 |
|
|
2019
Q2 | $36M | Sell |
369,549
-11,706
| -3% | -$1.07M | 0.39% | 42 |
|
|
2019
Q1 | $34.7M | Sell |
381,255
-2,846
| -0.7% | -$255K | 0.1% | 150 |
|
|
2018
Q4 | $34.9M | Sell |
384,101
-8,774
| -2% | -$820K | 0.42% | 41 |
|
|
2018
Q3 | $38.6M | Buy |
+392,875
| New | +$36.3M | 0.4% | 42 |
|
Other funds holding MDT
MetLife Investment Management's MDT Position: Q2 2026 in Review
MetLife Investment Management reduced its Medtronic (MDT) stake by 2% in Q2 2026, selling an estimated $472K and leaving 293,703 shares worth $23M. The position accounts for 0.1% of the portfolio, ranked #149.
MetLife Investment Management first reported a position in MDT in Q3 2018 and has held it in 32 quarters since. The position peaked at $40.6M in Q1 2022. 2,148 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- MetLife Investment Management held 293,703 shares of Medtronic worth $23M as of Q2 2026.
- MetLife Investment Management sold 5,857 Medtronic shares in Q2 2026, an estimated $472K.
- Medtronic made up 0.1% of MetLife Investment Management's portfolio in Q2 2026, its #149 holding.
- MetLife Investment Management first reported a position in Medtronic in Q3 2018 and has held it in 32 quarters since.
- MetLife Investment Management's Medtronic position peaked at $40.6M in Q1 2022.
- 2,148 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.